Curcuma Aeruginosa (Blue Turmeric)

Curcuma Aeruginosa (Blue Turmeric)

Product Name: Куркума голубоватая, Curcuma aeruginosa, Blaue Kurkuma, Cúrcuma azulada, Curcuma bleue, كركم أزرق, ขมิ้นอ้อย, Ko'k zerdecho, Көк куркума, Mavi zərdəçal, Зардчӯбаи кабуд, Mėlynoji ciberžolė, Zilā kurkuma, Куркума голубувата, כחול כורכום

Synonyms: куркума голубая, голубая куркума, синяя куркума, blue turmeric, wild blue turmeric, blue zedoary, blaue Kurkuma, Cúrcuma silvestre azul, Curcuma bleue sauvage, كركم بري أزرق, ขมิ้นป่า, ขมิ้นชันป่า

Parts Used: rhizome, leaves, stems, flowers, seeds.

Main Indications for Use of Curcuma aeruginosa: Chronic prostatitis, benign prostatic hyperplasia, dysmenorrhea, algomenorrhea, dyspepsia, functional biliary disorders, inflammatory diseases of the pelvic organs, fatty liver disease, gastritis with reduced secretion, intestinal dysbiosis, bronchial asthma, contact dermatitis, atopic dermatitis.

Use of Curcuma aeruginosa in Mixtures and Complexes: Chronic pancreatitis, gastric and duodenal ulcer, osteoarthritis, climacteric syndrome, neurodermatitis, anxiety disorders, chronic bronchitis, bacterial vaginosis.

Pharmacological Properties of Curcuma aeruginosa: anti-inflammatory, analgesic, antiandrogenic, antibacterial, antioxidant, hepatoprotective, choleretic, spasmolytic, immunomodulatory, antihypertrophic, wound-healing, anticarcinogenic, inhibiting phosphodiesterase-5, antipruritic.

Dosage of Pharmaceutical Forms — Curcuma aeruginosa

Powder — Curcuma aeruginosa

Indications (Powder): Chronic prostatitis, benign prostatic hyperplasia, algomenorrhea, dyspepsia, inflammatory diseases of the pelvic organs, fatty liver disease, gastritis with reduced secretion, intestinal dysbiosis.

Standard Dosage (Powder): 2 g of powder twice daily, 30 minutes before meals, washed down with warm water.

Enhanced Dosage (Powder): 3 g of powder 3 times a day for benign prostatic hyperplasia, algomenorrhea, and inflammatory diseases of the pelvic organs.

Maximum Dosage (Powder): No more than 12 g per day for chronic prostatitis with concomitant intestinal dysbiosis, for short-term use up to 7 days.

Preventive Dosage (Powder): 1 g of powder once daily in the morning on an empty stomach. Recommended for chronic forms of gastritis, fatty liver disease, and intestinal dysbiosis. Course — 21 days, repeat every 3 months.

Pediatric Dosage (Powder): For children from 7 years of age with a body weight from 25 kg — 0.5 g once daily. Only as prescribed by a physician. Use in children under 7 years of age is not recommended.

Contraindications (Powder): Acute inflammatory processes in the stomach, peptic ulcer in the exacerbation stage, gallstone disease with obstruction. Data on contraindications during pregnancy, lactation, and in childhood under 7 years of age have not been scientifically registered.

Side Effects (Powder): In case of overdose, dyspepsia, burning sensation in the stomach, and headache are possible.

Adjustment for Patient Body Weight (Powder): Patients with body weight less than 60 kg — reduce the dosage by 25%. Patients with body weight over 90 kg — a dose increase of 20% is permissible in the absence of contraindications.

Preparation Method (Powder): The rhizomes are thoroughly washed, peeled, and cut into slices no more than 3 mm thick. Dried in a dehydrator at a temperature of 45 degrees Celsius for 36 hours. Ground into powder in a mortar or mill. Sifted through a sieve with a mesh size of 0.3 mm. For 100 g of powder, 400 g of fresh raw material are required.

Storage Conditions and Shelf Life (Powder): Store in an airtight ceramic or glass container in a dark place at a temperature of 15 to 25 degrees Celsius. Avoid exposure to direct light, moisture, and EMI. Shelf life — 12 months. After opening — use within 60 days.

Dry Extract — Curcuma aeruginosa

Indications (Dry Extract): Benign prostatic hyperplasia, chronic prostatitis, fatty liver disease, bronchial asthma, contact dermatitis.

Standard Dosage (Dry Extract): 200 mg of dry extract 1–2 times a day after meals. Course — 30 days.

Enhanced Dosage (Dry Extract): 400 mg twice daily for chronic prostatitis and fatty liver disease in the subcompensation stage.

Maximum Dosage (Dry Extract): Up to 1200 mg per day for no more than 7 days for pronounced manifestations of benign prostatic hyperplasia. After — transition to the standard regimen.

Preventive Dosage (Dry Extract): 100 mg per day in the morning after meals. Recommended for men over 40 years of age with a predisposition to prostatic hyperplasia and patients with non-alcoholic hepatic steatosis. Course — 21 days every 3 months.

Pediatric Dosage (Dry Extract): Not recommended for children under 12 years of age. From 12 years — no more than 100 mg per day with a body weight from 40 kg.

Contraindications (Dry Extract): Acute cholecystitis, gallstones, individual hypersensitivity. Safety during pregnancy and lactation has not been established.

Side Effects (Dry Extract): In case of overdose, headache, insomnia, and increased gastric juice acidity are possible.

Adjustment for Patient Body Weight (Dry Extract): Up to 60 kg — a 25% dosage reduction. Over 90 kg — a 15–20% increase in the absence of adverse reactions.

Preparation Method (Dry Extract): 100 g of crushed dry rhizome are poured with 1000 ml of water. Maceration is carried out at a temperature of 60 degrees Celsius for 6 hours. Filtered and evaporated to a thick state in a water bath. The concentrate is dried at a temperature of 50–55 degrees Celsius in a vacuum dryer. The resulting extract is ground to a powder-like form.

Storage Conditions and Shelf Life (Dry Extract): Store in a tightly closed dark glass container at a temperature of 15–25 degrees Celsius under low humidity conditions. Shelf life — up to 24 months. After opening, use within 30 days.

Alcohol-Based Tincture — Curcuma aeruginosa

Indications (Tincture): Chronic prostatitis, algomenorrhea, functional biliary disorders, intestinal dysbiosis, bronchial asthma.

Standard Dosage (Tincture): 20 drops 3 times a day, 20 minutes before meals. Dilute in 30 ml of warm water.

Enhanced Dosage (Tincture): 30 drops 3 times a day for algomenorrhea and chronic prostatitis with pronounced pain syndrome.

Maximum Dosage (Tincture): No more than 40 drops 3 times a day for 5 days for acute attacks of bronchial asthma as part of complex therapy.

Preventive Dosage (Tincture): 15 drops per day on an empty stomach, course of 14 days every 2 months for chronic digestive disorders, intestinal dysbiosis, and mild forms of asthma.

Pediatric Dosage (Tincture): Not recommended for children under 14 years of age. From 14 years — 5–10 drops once daily only as prescribed by a physician.

Contraindications (Tincture): Alcoholism, epilepsy, stage II–III hypertension, pregnancy, lactation. Safety for children under 14 years of age has not been confirmed.

Side Effects (Tincture): Dizziness, tachycardia, irritation of the gastric mucosa when the dosage is exceeded.

Adjustment for Patient Body Weight (Tincture): Body weight less than 60 kg — the dosage is reduced by 25%. Over 90 kg — a correction upward by 20% is possible.

Preparation Method (Tincture): 100 g of dry crushed rhizome are poured with 500 ml of 40% ethyl alcohol. Infuse in a dark glass container at a temperature of 20–25 degrees Celsius for 10 days. Shake daily. After infusion — filter through gauze and store in a tightly sealed container.

Storage Conditions and Shelf Life (Tincture): Store in a dark, cool place at a temperature of 10 to 25 degrees Celsius. Avoid exposure to light and EMI. Shelf life — 2 years. After opening — use within 90 days.

Oil Infusion — Curcuma aeruginosa

Indications (Oil Infusion): Contact dermatitis, atopic dermatitis, dyspepsia, inflammatory diseases of the pelvic organs.

Standard Dosage (Oil Infusion): Externally: apply to affected skin areas twice daily. Orally: 1 teaspoon (5 ml) once daily after meals.

Enhanced Dosage (Oil Infusion): Externally — up to 3 times a day for pronounced itching or inflammation. Orally — up to 2 teaspoons per day for chronic dyspepsia and inflammatory gynecological pathologies.

Maximum Dosage (Oil Infusion): No more than 15 ml per day orally and 4 external applications per day for 7 days.

Preventive Dosage (Oil Infusion): Orally: 1/2 teaspoon once daily for 14 days. Externally: in courses of 7–10 days for the prevention of dermatitis relapses in the off-season.

Pediatric Dosage (Oil Infusion): From 5 years: externally — once daily on limited skin areas. Orally not used under 12 years of age.

Contraindications (Oil Infusion): Presence of open wounds, allergic contact dermatitis, individual intolerance. There are no scientifically confirmed data on safety during pregnancy and lactation.

Side Effects (Oil Infusion): In case of overdose, skin eruptions, itching, and a feeling of nausea with oral intake are possible.

Adjustment for Patient Body Weight (Oil Infusion): Patients up to 60 kg — a 30% dosage reduction. Over 90 kg — a 20% dosage increase is permissible externally.

Preparation Method (Oil Infusion): 100 g of crushed dry rhizome are poured with 400 ml of first cold-pressed coconut oil. Infuse in a water bath at a temperature of 45–50 degrees Celsius for 4 hours. Pour into an airtight jar and infuse at room temperature for another 7 days. Filter through cloth and pour into a sterile bottle.

Storage Conditions and Shelf Life (Oil Infusion): Store in a cool place (10–20 degrees Celsius), in dark glassware, without access to light and heat. Shelf life — 6 months. After opening — use within 30 days.

Lotion — Curcuma aeruginosa

Indications (Lotion): Contact dermatitis, atopic dermatitis, seborrheic dermatitis, hyperpigmentation, folliculitis, inflammatory elements of acne.

Standard Dosage (Lotion): Apply with a cotton pad twice daily to pre-cleansed skin of the face and body, avoiding the area around the eyes.

Enhanced Dosage (Lotion): Up to 3–4 times a day on areas with active inflammation and pronounced hyperpigmentation in seborrheic and contact dermatitis.

Maximum Dosage (Lotion): Up to 6 applications per day on limited zones (up to 10% of body surface), course up to 5 days for pronounced itching and inflammation.

Preventive Dosage (Lotion): Once daily in the evening in courses of 14 days monthly, especially during seasons of high humidity or allergic exacerbations. Recommended for chronic dermatitis and acne in the remission stage.

Pediatric Dosage (Lotion): From 8 years — once daily spot-wise. Under 8 years — not recommended.

Contraindications (Lotion): Pustular skin lesions, individual hypersensitivity, active eczema. No data on use during pregnancy and lactation.

Side Effects (Lotion): Burning, skin peeling, temporary increase in itching with individual sensitivity.

Adjustment for Patient Body Weight (Lotion): No adjustment is required, as the agent is applied locally.

Preparation Method (Lotion): For 100 ml of product: 5 g of dry Curcuma aeruginosa extract; 90 ml of distilled water; 5 ml of glycerin; 1 ml of lavender essential oil (optional). Dissolve the extract in water at a temperature of 40–45 degrees Celsius, add glycerin and oil, and stir until homogeneous. Pour into a sterile dispenser bottle.

Storage Conditions and Shelf Life (Lotion): Store at a temperature of 4–10 degrees Celsius in the refrigerator, away from light. Shelf life — 30 days. After opening — use within 14 days.

Ointment — Curcuma aeruginosa

Indications (Ointment): Contact dermatitis, eczema, psoriasis, inflammatory nodules in acne, localized hyperpigmentation, trophic ulcers.

Standard Dosage (Ointment): Apply in a thin layer to affected skin areas twice daily, course of 10–14 days.

Enhanced Dosage (Ointment): Up to 3–4 times a day for exacerbations of psoriasis and eczema with active peeling and itching.

Maximum Dosage (Ointment): Application 5 times a day, on no more than 10% of body surface, no more than 5 consecutive days.

Preventive Dosage (Ointment): Once daily before bedtime on areas prone to exacerbations (e.g., elbows, knees in psoriasis) for 7–10 days once a month.

Pediatric Dosage (Ointment): From 5 years — once daily on limited areas (up to 3% of body surface). Under 5 years, not recommended.

Contraindications (Ointment): Purulent skin lesions, skin tuberculosis, individual intolerance. There are no reliable data on use during pregnancy and lactation.

Side Effects (Ointment): Contact rash, itching, temporary increase in peeling.

Adjustment for Patient Body Weight (Ointment): No dose adjustment is required for external use.

Preparation Method (Ointment): For 100 g of ointment: 10 g of dry Curcuma aeruginosa extract; 80 g of unrefined coconut oil; 10 g of beeswax. Melt the wax and coconut oil in a water bath (to 50 degrees Celsius), add the extract, and stir until completely dissolved. Pour into sterile jars. Cool to room temperature.

Storage Conditions and Shelf Life (Ointment): Store in an airtight container in a dark, cool place at a temperature of 10–18 degrees Celsius. Shelf life — 6 months. After opening — use within 30 days.

Serum — Curcuma aeruginosa

Indications (Serum): Post-inflammatory hyperpigmentation, enlarged pores, seborrhea, inflammatory elements of acne, skin photoaging, loss of elasticity of the skin of the face and neck.

Standard Dosage (Serum): Apply 2–3 drops to clean facial skin once daily in the evening, gently distributing over the skin surface until absorbed.

Enhanced Dosage (Serum): Up to 2 times a day for pronounced hyperpigmentation, inflammations, and photodamage of the skin.

Maximum Dosage (Serum): Up to 4 applications per day spot-wise on problem areas for folliculitis and severe seborrhea. Duration — no more than 7 consecutive days.

Preventive Dosage (Serum): 1 drop every other day in the evening, course of 14 days each month for patients with sensitive skin prone to age-related changes and stress inflammations.

Pediatric Dosage (Serum): Use is not recommended under 14 years of age. From 14 years — spot-wise once daily for acne, after consultation with a specialist.

Contraindications (Serum): Individual intolerance, open microcracks, active pustular eruptions. Data on contraindications during pregnancy and lactation have not been established.

Side Effects (Serum): Redness, itching, burning sensation, peeling with skin hypersensitivity.

Adjustment for Patient Body Weight (Serum): No adjustment is required; applied externally in microdoses.

Preparation Method (Serum): For 100 ml of product: 3 g of dry Curcuma aeruginosa extract; 90 ml of distilled water; 5 ml of aloe vera gel; 1 ml of 1% hyaluronic acid; 1 ml of green tea extract. Combine the components at a temperature not exceeding 40 degrees Celsius, stir until completely dissolved. Pour into a sterile pipette bottle.

Storage Conditions and Shelf Life (Serum): Store in the refrigerator at a temperature of 4–8 degrees Celsius, in dark glass packaging. Shelf life — 30 days. After opening — use within 14 days.

Essential Oil — Curcuma aeruginosa

Indications (Essential Oil): Bronchial asthma, contact dermatitis, anxiety disorders, inflammatory diseases of the upper respiratory tract, tension headaches.

Standard Dosage (Essential Oil): Aromatherapy: 2 drops in an aroma diffuser per 15–20 m² of room 1–2 times a day. Externally: 1 drop per 10 ml of base oil, apply to temples, chest, neck.

Enhanced Dosage (Essential Oil): Up to 3 drops in the aroma diffuser and up to 2 drops in the base oil for pronounced asthma, bronchitis, and psychoemotional stress.

Maximum Dosage (Essential Oil): Aroma diffuser: no more than 5 drops per day. External application: no more than 4 drops per 20 ml of base oil, twice daily. Use no longer than 7 consecutive days.

Preventive Dosage (Essential Oil): 1 drop in the diffuser daily before bedtime, course of 10 days each month. Recommended for a tendency to bronchospasms and tension headaches.

Pediatric Dosage (Essential Oil): From 7 years: no more than 1 drop in the diffuser in the presence of the child. External use is not recommended for children under 12 years of age.

Contraindications (Essential Oil): Epilepsy, stage III hypertension, pregnancy (first trimester), childhood under 7 years of age. Photosensitization is possible when applied to the skin.

Side Effects (Essential Oil): Headache, dizziness, nausea, irritation of mucous membranes.

Adjustment for Patient Body Weight (Essential Oil): No adjustment is required for aromatherapeutic use. Externally — reduce the concentration in patients up to 60 kg.

Preparation Method (Essential Oil): To obtain 100 ml of essential oil, 8 kg of fresh rhizome are required. Steam distillation is carried out in a stainless steel apparatus. Oil collection — from the condensate on the surface, separation from the hydrolate manually. Distillation time — 3 hours at a temperature of 98–100 degrees Celsius.

Storage Conditions and Shelf Life (Essential Oil): Store in an airtight dark glass bottle at a temperature of 10–20 degrees Celsius, away from sources of light and EMI. Shelf life — 12 months. After opening — use within 90 days.

Toxicity and Biosafety of Curcuma aeruginosa

Experimental studies on animal models have shown low acute toxicity of Curcuma aeruginosa. With oral administration of the alcohol extract to mice, the LD50 value is more than 5000 mg/kg body weight, which indicates very low toxicity and relative safety with therapeutic use. In subchronic tests (90 days) in rats, with intake of doses up to 1000 mg/kg/day, no signs of organ toxicity, mutagenicity, or carcinogenicity were detected. Adverse reactions were observed only when the dosage was exceeded by 10–15 times compared with the therapeutic one.

According to in vitro and in vivo data, Curcuma aeruginosa extracts do not cause cytotoxicity with respect to cells of the liver, intestinal epithelium, and reproductive system. The use of essential oil also did not show signs of toxic action with inhalation and external use.

Reference: https://www.ncbi.nlm.nih.gov/p...

Pharmacodynamics — Curcuma aeruginosa

Curcuma aeruginosa exhibits a wide spectrum of pharmacodynamic effects due to the presence of biologically active compounds, predominantly sesquiterpenes, essential oils, and phenolic derivatives. Experimental and clinical data confirm its activity at the systemic and local levels in interaction with key physiological systems.

At the level of the immune system, modulation of pro-inflammatory cytokines is observed, including interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), and cyclooxygenase-2 (COX-2). A decrease in the expression of these mediators contributes to the realization of the anti-inflammatory effect, which is documented both in vitro and in vivo. Signs of inhibition of histamine release by mast cells have also been recorded, which may indicate a potential for membrane stabilization and reduction of hyperreactivity.

On the part of the nervous system, activation of GABAergic mechanisms has been revealed, presumably due to an increase in the density or sensitivity of GABA receptors. This may mediate a mild sedative effect and a reduction in neuroinflammation. Antinociceptive activity has also been noted, associated with suppression of pain impulse transmission at the spinal and supraspinal levels.

The pharmacological effect on the gastrointestinal tract is realized through stimulation of bile production and normalization of motility, which is due to a possible interaction with the cholinergic system. An indirect influence on the microbiome is noted in the form of suppression of the growth of pathogenic strains of bacteria and fungi, while conditionally commensal microflora is preserved.

On the part of the skin system, Curcuma aeruginosa extracts exhibit pronounced antioxidant properties due to the presence of free phenolic groups. These compounds effectively neutralize reactive oxygen species and inhibit lipid peroxidation, providing protection of cell membranes. The antiseptic and wound-healing effect is associated with inhibition of microbial proliferation and activation of the proliferative phase of regeneration.

There are also data on interaction with androgen receptors, which may explain specific effects with respect to the epithelium of the prostate gland and skin appendages. In silico studies indicate possible competitive binding with receptor sites of 5-alpha-reductase enzymes, which forms an additional mechanism of antiproliferative action.

The combination of effects observed with local and systemic use confirms the multi-target activity of the preparation and its ability to intervene in the cascades of inflammatory, endocrine, antioxidant, and membrane-stabilizing processes.

References:
https://www.ncbi.nlm.nih.gov/p...
https://www.sciencedirect.com/...
https://link.springer.com/arti...

Pharmacokinetics — Curcuma aeruginosa

The pharmacokinetic characteristics of preparations from Curcuma aeruginosa depend on the dosage form used and the routes of administration. The most common are oral, transdermal, and inhalation routes. The absorption of active components with oral intake occurs predominantly in the small intestine. Bioavailability may be limited due to high lipophilicity and a tendency to metabolic transformation in the liver. This applies primarily to sesquiterpenes and essential oils present in the composition of extracts and powders.

With external application (ointment, infusion, lotion), transdermal absorption is limited by the stratum corneum of the epidermis but can be enhanced by the use of oil bases such as coconut oil, which possesses high penetrating ability. The absorbed substances reach the dermal layer and can partially penetrate into the systemic bloodstream, exhibiting systemic activity with prolonged use.

Inhalation intake of volatile components through aroma diffusers ensures rapid achievement of therapeutic concentration in the central nervous system and respiratory tract. This is explained by the high permeability of the respiratory mucosa and the absence of first-pass through the liver.

The distribution of active substances, according to pharmacological data on related species (Curcuma longa, Curcuma zedoaria), occurs predominantly in the liver, skin, kidneys, and adipose tissue. Local accumulation is associated with the high affinity of lipophilic compounds for cell membranes.

Metabolism is carried out predominantly in the liver with the participation of enzyme systems of cytochrome P450. Biotransformation includes phases of oxidation and conjugation (sulfation and glucuronidation). The resulting metabolites possess lower activity and are excreted predominantly by the kidneys and through bile.

Preparations based on Curcuma aeruginosa can influence the intestinal microflora, contributing to the suppression of pathogenic microorganisms and improvement of conditions for the growth of probiotic strains. This interaction enhances the systemic effect by reducing the endotoxic load and stimulating mucosal immunity.

References:
https://www.sciencedirect.com/...
https://pubmed.ncbi.nlm.nih.go...
https://www.tandfonline.com/do...

Mechanisms of Action and Scientific Rationale — Curcuma aeruginosa

The mechanisms of action of the biologically active components of Curcuma aeruginosa are determined primarily by the presence of sesquiterpenes, phenolic compounds, and essential oils possessing high biofunctional activity. In in vitro studies, it has been established that alcohol and essential extracts of the plant inhibit the expression of pro-inflammatory enzymes — in particular, cyclooxygenase-2 (COX-2) and lipoxygenase (LOX), and also reduce the production of prostaglandins and leukotrienes mediating inflammatory and pain reactions. These effects are complemented by inhibition of the activation of the transcription factor NF-κB, which indicates a decrease in the cellular response to inflammatory stimuli.

The ability of the active substances of Curcuma aeruginosa to influence the MAPK and JAK/STAT signaling pathways has also been observed, which is confirmed by a decrease in the phosphorylation of STAT3 and ERK1/2 when cells are treated with the corresponding extracts. These cascades play an important role in the regulation of cell proliferation, apoptosis, and immune response. Modulation of the activity of these signaling systems may explain the antiproliferative and immunoregulatory properties of the plant.

An additional pharmacodynamic interest is aroused by the influence of Curcuma aeruginosa on antioxidant mechanisms. It has been shown that plant extracts increase the activity of superoxide dismutase (SOD), catalase, and glutathione peroxidase, and also reduce the level of malondialdehyde (MDA), reflecting the degree of lipid peroxidation. Such properties provide protection of tissues from oxidative stress, especially under conditions of chronic inflammatory processes.

Curcuma aeruginosa also interacts with neurotransmitter systems. Studies on animal models show the potential for inhibition of acetylcholinesterase (AChE), which may be important for neuromodulatory activity. In addition, the essential fraction of the plant contains components demonstrating affinity for GABA-type receptors, contributing to mild sedation and reduction of anxiety.

Extracts of the rhizome of Curcuma aeruginosa have demonstrated antibacterial activity against a wide spectrum of gram-negative and gram-positive microorganisms, including antibiotic-resistant strains. The presumed mechanism is disruption of the integrity of the microbial membrane and inhibition of the synthesis of proteins and DNA. A decrease in the expression of virulence genes in some pathogens under the influence of terpene components of the plant has also been established.

Among additional mechanisms — inhibition of androgen receptors, influence on the activity of phosphodiesterase-5, as well as modulation of the cellular response of epithelial structures, which opens up possibilities for tissue-specific effects without systemic intervention.

References:
https://www.ncbi.nlm.nih.gov/p...
https://www.sciencedirect.com/...
https://link.springer.com/arti...
https://www.tci-thaijo.org/ind...

Synergy — Curcuma aeruginosa

In vitro and in vivo data confirm synergistic interactions between the components of Curcuma aeruginosa and a number of other phyto-substances, which contributes to the enhancement of its pharmacological effects. In particular, combination with extracts of Zingiber officinale leads to potentiation of the inhibition of pro-inflammatory cytokines (TNF-α, IL-1β), as well as a pronounced decrease in the activity of COX-2 and iNOS. This interaction is additive and partially potentiating in nature, realized at the level of macrophages and endothelium.

The combined use of Curcuma aeruginosa with Andrographis paniculata demonstrates a modulating effect on the JAK/STAT and MAPK signaling cascades, which contributes to deeper control of proliferative and immune reactions. Such combinations may possess tissue-specific action, predominantly at the level of mucous membranes and lymphoid tissue.

When used as part of oil compositions based on coconut or sesame oil, an improvement in the transdermal delivery of terpene components is observed, which increases the degree of bioavailability and prolongation of action. Oil bases also play the role of stabilizers and protective carriers, contributing to the uniform release of active substances.

In combination with vitamins of the antioxidant spectrum (e.g., α-tocopherol or ascorbic acid), a synergistic enhancement of antioxidant activity is recorded, measured through an increase in the activity of catalase and glutathione peroxidase enzymes, as well as a decrease in the concentration of MDA in tissues.

Enzymatic interactions of Curcuma aeruginosa with flavonoid structures present in such plants as Camellia sinensis and Ginkgo biloba confirm additive enhancement of antioxidant, membrane-stabilizing, and anti-inflammatory effects. The presumed mechanism is joint inhibition of the NF-κB signaling pathway and suppression of the production of reactive oxygen species.

Thus, the synergistic potential of Curcuma aeruginosa is due both to interaction at the level of receptor and enzyme systems and to an increase in the physicochemical stability of active components with combined use with natural substances possessing a similar spectrum of action.

References:
https://www.sciencedirect.com/...
https://www.ncbi.nlm.nih.gov/p...
https://www.tandfonline.com/do...

Geography of Use and Traditional Medicine — Curcuma aeruginosa

Curcuma aeruginosa is traditionally used in the regions of Southeast Asia, predominantly in the territory of Thailand, Malaysia, Indonesia, Cambodia, and Laos. The plant has received the widest distribution within the framework of Thai traditional medicine, as well as in Malay ethnomedical practice, where it is known under the names khamin oi and temu ireng. Historical sources, including handwritten treatises and wall medical frescoes in the temples of Siam, indicate the use of the plant at least since the 17th century. The first written mention in European sources dates back to the 19th century and is associated with the works of naturalists of the British East India Company.

In traditional Thai medicine, the powder and rhizome of Curcuma aeruginosa are used externally in the form of pastes, wraps, and oil infusions for skin care and as a restorative agent after childbirth. Of particular importance is the ritual practice of using the rhizome in postpartum purification and restoration of female energy, which is associated with the concept of lom — winds of the body. The plant was also considered to purify spirit and body and was used by shamans of the Mon-Khmer peoples in rituals of purification of the dwelling, as well as part of aromatic compositions for protection from evil spirits.

In Malaysia, Curcuma aeruginosa is part of ritual incenses known as beras kunyit, where the powder is mixed with rice and used for fumigating space during illness or misfortune. In the Indonesian folk tradition, the plant is known as part of women's restorative mixtures jamu, used after childbirth to strengthen the body and restore energy. It is believed that its rhizome symbolizes protection and rebirth.

In the cultures of Southeast Asia, blue turmeric can be used as a ritual amulet placed in the corners of the house or under the threshold, as well as an amulet to protect newborns. Practices of rubbing the body with a paste from the plant before holidays or rites of passage, including wedding ceremonies and initiations, are also known.

In ethnographic descriptions of Lao and Khmer peoples, the use of the plant as a component of ritual baths accompanying traditions of expelling diseases and purification from "impure influences" is indicated. Decoctions of the rhizome added to water for washing the body and hair were often used, which was combined with the aromatherapeutic action of the volatile compounds of the plant.